XBiotech USA Revenue

Biotechnology Research • Austin, Texas, United States • 51-100 Employees

XBiotech USA revenue & valuation

Annual revenue	$4,010,000
Revenue per employee	$41,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,900,000
Total funding	No funding

Key Contacts at XBiotech USA

Victor Rowell

Director Of It

Ty Mclean

Facilities Director

Michael Cavalier

Senior Director Of Manufacturing

Tzu-Yu Kwan

Associate Director Of Cell Line Development

Angela Hu

Director Of Finance

Parker P

Director Of Research

Company overview

Headquarters	5217 Winnebago Ln, Austin, Texas 78744, US
Phone number	+15123862900
Website	xbiotech.com
NAICS	541714
SIC	873
Keywords	First-In-Class Monoclonal Antibody
Founded	2005
Employees	51-100
Socials

XBiotech USA Email Formats

XBiotech USA uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@xbiotech.com), used 71.4% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@xbiotech.com	71.4%
{first name}{last name}	johndoe@xbiotech.com	12.5%
{last name}{last name}	doedoe@xbiotech.com	12.5%
{first initial}.{last name}	j.doe@xbiotech.com	1.8%
{first initial}{first initial}	jj@xbiotech.com	1.8%

About XBiotech USA

XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Unlike previous generations of antibody therapies, XBiotech’s True Human™ antibodies are 100 percent human, derived from individuals who possess natural immunity to certain diseases. With discovery and clinical programs across multiple disease areas, XBiotech’s True Human™ antibodies have the potential to harness the body’s natural immunity to fight disease with increased safety, efficacy and tolerability. XBiotech is currently advancing a robust pipeline of antibody therapies to exceed the standards of care in oncology, inflammatory conditions and infectious diseases. The Company's broad pipeline of True Human™ antibodies are able to potentially deliver unmatched safety and efficacy because they are cloned directly from individual donors who possess natural immunity against certain targeted diseases. As such, True Human™ antibodies retain their natural physiology and tolerance profile, having passed the rigors of immune selection in the body.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

XBiotech USA has 42 employees across 6 departments.

Departments

Number of employees

Funding Data

XBiotech USA has never raised funding before.

XBiotech USA Tech Stack

Discover the technologies and tools that power XBiotech USA's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

GoDaddy

Hosting

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

Google Font API

Font scripts

Sendgrid

Frequently asked questions

XBiotech USA is located in Austin, Texas, US.

You can reach XBiotech USA at +15123862900.

XBiotech USA generates an estimated annual revenue of $4,010,000. This revenue figure reflects the company's market position and business performance in its industry.

XBiotech USA has an estimated valuation of $12,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

XBiotech USA was founded in 2005, making it 21 years old. The company has established itself as a significant player in its industry over this time.

XBiotech USA has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.